Companies: 10,795·Total market cap: $144.5T
BioSyntech, Inc.

BioSyntech, Inc.

BSYIOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$229033
P/E Ratio
52W High$0.00001
52W Low$0.000001

BioSyntech, Inc. (BSYI) Revenue

Annual & quarterly revenue history · segment & region breakdown

BSYI · revenue · updated Jun 9, 2026

Core revenue metrics

BioSyntech, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
1.15×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
0 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · BioSyntech, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
BSYI revenue by year · BSYI revenue history · BSYI annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income BioSyntech, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

BioSyntech, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from BioSyntech, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

BSYI revenue · 4 questions

BSYI's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

BSYI revenueBSYI annual revenuewhat is BSYI revenueBSYI TTM revenue

Source: FMP · BioSyntech, Inc. SEC filings · GAAP · BioSyntech, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026